← Eichor
Study identifier: NCT03615690 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Influence of a Fasting Mimicking Diet on Ulcerative Colitis

Condition: Inflammatory Bowel Disease · Diet Modification · Ulcerative Colitis  ·  Sponsor: Stanford University

PhaseNA
Planned participants75
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

The purpose of this study is to see how a diet that mimics fasting effects inflammation in patients with mild to moderate Ulcerative Colitis (UC). The diet may allow users to receive the benefits of fasting while also being able to enjoy food (the ingredients of which are GRAS (generally recognized as safe) by the Food and Drug Administration (FDA). Research on dietary interventions and UC are very limited. Fasting mimicking diets (FMD) have been studied with support of the National Institute of Health and published in leading journals. This research investigates whether markers of inflammation decrease and/or quality of life increases after three cycles of a five-day period of the fasting mimicking diet, and may provide rationale for its use to treat UC.

This description comes directly from the study's public registry record.

Talk to the study team

Touran Fardeen  ·  6507367311  ·  tfardeen@stanford.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Stanford UniversityPalo Alto, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03615690